DK90589A - Anvendelse af chymotrypsin til at goere praekallikrein-aktivatoren uvirksom - Google Patents

Anvendelse af chymotrypsin til at goere praekallikrein-aktivatoren uvirksom

Info

Publication number
DK90589A
DK90589A DK090589A DK90589A DK90589A DK 90589 A DK90589 A DK 90589A DK 090589 A DK090589 A DK 090589A DK 90589 A DK90589 A DK 90589A DK 90589 A DK90589 A DK 90589A
Authority
DK
Denmark
Prior art keywords
chymotrypsin
preparations
preekallikrein
make
immobilised
Prior art date
Application number
DK090589A
Other languages
English (en)
Other versions
DK90589D0 (da
Inventor
Yendra Linnau
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of DK90589D0 publication Critical patent/DK90589D0/da
Publication of DK90589A publication Critical patent/DK90589A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK090589A 1988-02-26 1989-02-24 Anvendelse af chymotrypsin til at goere praekallikrein-aktivatoren uvirksom DK90589A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0049488A AT391810B (de) 1988-02-26 1988-02-26 Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators

Publications (2)

Publication Number Publication Date
DK90589D0 DK90589D0 (da) 1989-02-24
DK90589A true DK90589A (da) 1989-08-27

Family

ID=3492093

Family Applications (1)

Application Number Title Priority Date Filing Date
DK090589A DK90589A (da) 1988-02-26 1989-02-24 Anvendelse af chymotrypsin til at goere praekallikrein-aktivatoren uvirksom

Country Status (9)

Country Link
US (2) US5094949A (da)
EP (1) EP0330647B1 (da)
JP (1) JPH07116052B2 (da)
AT (2) AT391810B (da)
CA (1) CA1338499C (da)
DE (1) DE58905495D1 (da)
DK (1) DK90589A (da)
ES (1) ES2059826T3 (da)
FI (1) FI93696C (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT391810B (de) * 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators
BR0316563A (pt) * 2002-11-25 2005-10-04 Octapharma Ag Fração de albumina derivada de plasma exaurido de prekallikrein
ES2221817B1 (es) * 2004-07-26 2005-10-01 Probitas Pharma, S.A. "soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas".
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU469815B2 (en) * 1971-04-14 1973-10-18 Anti-inflammatory compositions
DE2835843A1 (de) * 1978-08-16 1980-02-28 Blutspendedienst Dt Rote Kreuz Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung
US4272521A (en) * 1979-07-16 1981-06-09 Cutter Laboratories, Inc. Purified immune serum globulin
US4251510A (en) * 1979-08-15 1981-02-17 Cutter Laboratories, Inc. Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
NL8220181A (nl) * 1982-05-31 1984-04-02 Mochida Pharm Co Ltd Geimmobiliseerd pepsine voor gebruik in de verwijdering van immuuncomplex uit bloed, en een werkwijze voor het verwijderen van immuuncomplex uit bloed door gebruik van het geimmobiliseerde pepsine.
AT376367B (de) * 1983-03-16 1984-11-12 Immuno Ag Verfahren zur herstellung von therapeutisch verabreichbaren, in endbehaeltern abgefuellten plasmaderivaten
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
AT390560B (de) * 1986-05-30 1990-05-25 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
AT391810B (de) * 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators

Also Published As

Publication number Publication date
US5324628A (en) 1994-06-28
ES2059826T3 (es) 1994-11-16
EP0330647A3 (en) 1990-05-09
EP0330647B1 (de) 1993-09-08
FI93696B (fi) 1995-02-15
FI93696C (fi) 1995-05-26
DE58905495D1 (de) 1993-10-14
JPH01261332A (ja) 1989-10-18
DK90589D0 (da) 1989-02-24
CA1338499C (en) 1996-07-30
JPH07116052B2 (ja) 1995-12-13
ATA49488A (de) 1990-06-15
ATE94071T1 (de) 1993-09-15
AT391810B (de) 1990-12-10
FI890907A0 (fi) 1989-02-24
FI890907L (fi) 1989-08-27
US5094949A (en) 1992-03-10
EP0330647A2 (de) 1989-08-30

Similar Documents

Publication Publication Date Title
DK0431129T3 (da) Fremgangsmåder til inaktivering af virus i viruskontaminerede farmaceutiske præparater
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
MX9203370A (es) Desulfatohirudina y composiciones farmaceuticas que la contienen.
DK0600866T3 (da) Præparater og fremgangsmåder til identifikation af biologisk aktive molekyler
DK442688D0 (da) Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser
DK155500C (da) Fremgangsmaade til fremstilling af blodkoagulationsfremmende praeparater paa basis af humanproteiner
ATA117890A (de) Komplexes virales antigen von hiv-1 bindendes rekombinantes protein
DE69005959D1 (de) Verfahren zur Reinigung von menschlichem Serum-Albumin.
DE59209129D1 (de) Verwendung von Antikörper enthaltenden Präparationen zur Immunsuppression
DK41590A (da) Forbedrede protein c-molekyler samt fremgangsmaade til fremstilling og aktivering af samme
AU2567888A (en) Hiv peptides and methods for detection of hiv
DK90589D0 (da) Anvendelse af chymotrypsin til at goere praekallikrein-aktivatoren uvirksom
DE50011030D1 (de) Verfahren zur chromatographischen fraktionierung von plasma oder serum, so erhaltene präparate und deren verwendung
ES2165884T3 (es) Preparacion farmaceutica estable que no contiene actividad viral consistente en al menos un 70%, preferiblemente un 90% de inmunoglobulina a humana monomera, y procedimiento de preparacion.
ATE124539T1 (de) Immunogen und seine verwendung zur gewinnung von antikörpern gegen hba1c.
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
DK226889A (da) Alkoholpeptidderivat samt anvendelse deraf til mindskning af blodkoagulation
NO890129D0 (no) Fremgangsmaate ved inaktivering av sykdomsfremkallende materialer i blodplasmaprodukter.
DE3750886D1 (de) Verwendung eines immunglobulinhaltigen Präparates zur Prophylaxe und Therapie von AIDS beim Menschen.
DK131284A (da) Fremgangsmaade til inaktivering af stoffer, der foraarsager uforenelighedsreaktioner
DK0565512T3 (da) Fremgangsmåde til aktivering af blodkoagulationsfaktorer
ATE194648T1 (de) Verfahren zur inaktivierung von viren in präparationen von proteinen
DE68919697D1 (de) Katalytische hydrofluorierung von alkenen.
DK163281A (da) Fremgangsmaade til fremstilling af ukoagulerbart blod ved hjaelp af proteolytiske enzymer og proteinkoncentrat fremstillet deraf
DE69631528D1 (de) Serumzusammensetzungen zur hemmung von retroviren und tumorwachstum